Worldwide Prevalence of Hepatitis B and C Among Patients with Cirrhosis

Empirical, updated country-level estimates on the proportion of cirrhosis attributable to viral hepatitis are required.

A systematic review, published in The Lancet Gastroenterology & Hepatology, estimated the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in patients with cirrhosis at country, regional, and global levels as an approximation for the fractions of cirrhosis attributable to viral hepatitis.

Full study results can be accessed here.